Skip to main content
UCB's Global Corporate Website
instagram
facebook
twitter
youtube
linkedin
rss
Listen
25 Apr 2013
UCB's shareholder meeting today
Read More
25 Apr 2013
Slow Start but Outlook 2013 and Growth Prospects Confirmed
Read More
28 Mar 2013
Acquisition of own shares
Read More
19 Mar 2013
New data Released on Switching Parkinson's Disease Patients with Pre-Existing Gastrointestinal Symptoms from Oral PD Medications to Neupro® (Rotigotine Transdermal System)
Read More
19 Mar 2013
UCB and Five Prime Therapeutics announce strategic discovery collaboration
Read More
14 Mar 2013
Acquisition of own shares
Read More
11 Mar 2013
Acquisition of own shares
Read More
11 Mar 2013
UCB successfully completes its fixed rate Bond issue
Read More
7 Mar 2013
UCB launches 7-year 3.75% fixed rate Retail Bonds
Read More
5 Mar 2013
VIMPAT® (lacosamide) generates positive results in US Phase 3 monotherapy study
Read More
Pagination
First page
Previous page
‹ Previous
…
Page
53
Page
54
Page
55
Page
56
Current page
57
Page
58
Page
59
Page
60
Page
61
…
Next page
Next ›
Last page
Subscribe to
Choose a Country
Global Site – English
Australia – English
België – Engels
Belgique – Anglais
Brasil – Português
България – Български
Canada – English
Canada – Français
中国 – 中文
Česká Republika – Angličtina
Danmark – Engelsk
Deutschland – Deutsch
France – Français
España – Español
Ελλάδα – Ελληνικά
India – English
Ireland – English
Italia – Inglese
日本 – 日本語
한국 – 한국어
Luxembourg – Anglais
Luxemburg – Engels
Magyarország – Angol
México & Latinoamérica – Español
Nederland – Engels
New Zealand – English
Norge – Engelsk
Österreich – Deutsch
Polska – Polski
Portugal – español y portugués
România – Engleză
Россия – Русский
Slovensko – Anglický
Suomi – Englanti
Sverige – Engelska
Schweiz – Deutsch
Türkiye – Türkçe
Україна – Англійська
United Kingdom – English
U.S.A. – English
×
instagram
facebook
twitter
youtube
linkedin
rss